Operates in pharmaceutical manufacturing and research. Offers formulations across multiple therapeutic segments. Revenue is derived from sales to distributors and healthcare institutions. Focuses on compliance and quality. Serves domestic and export markets. Operates science-driven pharma model.
Loading chart…
This company hasn't held an earnings call in the last six months, so there's no recent commentary from management. Our deep dives are built on what management actually said, so we haven't prepared one.
25 fields couldn't be derived. The company was scraped before the cash-flow and balance-sheet rows were captured. Re-running an analysis will refresh these.